/Companies

Immunoscape

Singapore, SG · Founded 2016 · 22 employees on LinkedIn · 1 known investors

Find your way into Immunoscape

Sign up to see every warm intro you have to Immunoscape

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunoscape team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.

Founders & leadership

Immunoscape was founded in 2016 by Michael Fehlings, PhD, Evan Newell, PhD, and Alessandra Nardin, DVM.

MF
Michael Fehlings, PhDCo-founder, Chief Executive Officer
ENEvan Newell, PhD
Evan Newell, PhDCo-founder/Advisor
AN
Alessandra Nardin, DVMCo-founder, Vice President Strategy

Investors · 1

Frequently asked questions

What does Immunoscape do?
ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.
Who founded Immunoscape?
Immunoscape was founded by Michael Fehlings, PhD, Evan Newell, PhD, Alessandra Nardin, DVM in 2016.
Who are Immunoscape's investors?
Immunoscape's investors include Anzu Partners.
Where is Immunoscape headquartered?
Immunoscape is headquartered in Singapore, SG.